v3.26.1
Unaudited Condensed Statements of Changes in Shareholders’ Equity (Deficit) - 3 months ended Mar. 31, 2026 - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
 [1]
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Total
Balance at Dec. 31, 2025 $ 25,000 $ (58,311) $ (33,311)
Balance (in Shares) at Dec. 31, 2025 3,833,333      
Issuance of Public Rights, net of issuance cost 3,421,660 3,421,660
Allocated value of transaction costs to redeemable shares (28,340) (28,340)
Private Placement Proceeds 2,900,000 2,900,000
Private Placement Proceeds (in Shares) 290,000        
Issuance of Representative Shares 67,312 67,312
Issuance of Representative Shares (in Shares) 43,125        
Accretion of carrying value to redemption value (4,337,989) (4,337,989)
Subsequent measurement of ordinary shares subject to redemption (interest earned on trust account) (627,232) (627,232)
Net Income 547,961 547,961
Balance at Mar. 31, 2026 $ 1,420,411 $ 489,650 $ 1,910,061
Balance (in Shares) at Mar. 31, 2026 333,125 3,833,333      
[1] As a result of the underwriters’ representative’s full exercise of its over-allotment option to purchase 1,500,000 units on February 3, 2026, no shares were subject to forfeiture.